Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

November 17, 2023

Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute

Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute

By John Howser
Mark Denison, MD, and Xiaotao Lu, MS, are among those on a new list of scientists whose papers have been cited the most frequently by other researchers. (photo by Erin O. Smith)
November 15, 2023

Twelve at Vanderbilt are among world’s highly cited researchers

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.

By Bill Snyder
November 3, 2023

GE Healthcare, Vanderbilt University Medical Center and the University Medicine Essen validate Artificial Intelligence models for predicting patient response to immunotherapies

By VUMC News and Communications
October 26, 2023

Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center

Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center

By Tom Wilemon
October 17, 2023

Vanderbilt-Ingram Cancer Center earns NCI Merit Award

Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.

By Tom Wilemon
October 12, 2023

Prostate cancer survivors symposium set for Nov. 11

Vanderbilt University Medical Center Department of Urology and Vanderbilt-Ingram Cancer Center are hosting a symposium for prostate cancer survivors and their families on Saturday, Nov. 11.

By Tom Wilemon
October 12, 2023

Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4

A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer.
By Tom Wilemon
October 10, 2023

Multidisciplinary care crucial in guiding Vanderbilt employee’s bile duct cancer journey

Blane Hollingsworth became the first patient at Vanderbilt to undergo a liver transplant under the protocol for cholangiocarcinoma, or bile duct cancer.
By Matt Batcheldor
October 5, 2023

Study validates pyrvinium as treatment to prevent stomach cancer

A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.
By Tom Wilemon
October 4, 2023

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
By Tom Wilemon
September 19, 2023

Beauchamp honored at symposium highlighting basic research by surgeon scientists

The profound impact of R. Daniel Beauchamp, MD, former chair of the Section of Surgical Sciences at Vanderbilt University Medical Center, was deeply evident at a recent symposium highlighting basic research conducted by numerous surgeons and physician-scientists, all of whom were closely associated with the noted physician-scientist.
By Jill Clendening
September 12, 2023

Study finds new genetic susceptibilities for colon cancer

Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer. 
By Tom Wilemon
September 1, 2023

Foundation funds research to block drug resistance in cancer treatment

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.
By Tom Wilemon
1 … 4 5 6 7 8 … 25